360 related articles for article (PubMed ID: 3740078)
21. Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus.
Garabet L; Gilboe IM; Mowinckel MC; Jacobsen AF; Mollnes TE; Sandset PM; Jacobsen EM
Scand J Immunol; 2016 Aug; 84(2):95-9. PubMed ID: 27135178
[TBL] [Abstract][Full Text] [Related]
22. Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.
Hiramatsu Y; Isoda K; Kotani T; Nakamura E; Wada Y; Fujiki Y; Makino S; Fujita D; Takeuchi T
Arthritis Res Ther; 2021 May; 23(1):140. PubMed ID: 33980284
[TBL] [Abstract][Full Text] [Related]
23. Progressive reduction of serum complement levels: a risk factor for relapse in patients with hypocomplementemia in systemic lupus erythematosus.
Miyawaki Y; Sada K; Asano Y; Hayashi K; Yamamura Y; Hiramatsu S; Ohashi K; Morishita M; Watanabe H; Matsumoto Y; Kawabata T; Wada J
Lupus; 2018 Nov; 27(13):2093-2100. PubMed ID: 30309286
[TBL] [Abstract][Full Text] [Related]
24. Three distinct profiles of serum complement C4 proteins in pediatric systemic lupus erythematosus (SLE) patients: tight associations of complement C4 and C3 protein levels in SLE but not in healthy subjects.
Wu YL; Higgins GC; Rennebohm RM; Chung EK; Yang Y; Zhou B; Nagaraja HN; Birmingham DJ; Rovin BH; Hebert LA; Yu CY
Adv Exp Med Biol; 2006; 586():227-47. PubMed ID: 16893076
[TBL] [Abstract][Full Text] [Related]
25. Dietary Habits in Patients with Systemic Lupus Erythematosus.
Petrić M; Božić J; Radić M; Perković D; Petrić M; Martinović Kaliterna D
J Med Food; 2020 Nov; 23(11):1176-1182. PubMed ID: 32150485
[TBL] [Abstract][Full Text] [Related]
26. Determination of serum free light chains as a marker of systemic lupus flare.
Rodríguez-Cambrón AB; Jiménez-Jiménez J; Blázquez-Cañamero MÁ; Pazos FR; Macía-Villa C; Alcalde-Villar M; Collado-Ramos P; Del Pozo FMC; Álvarez-Andrés E; Cruz-Valenciano A
Clin Rheumatol; 2020 Feb; 39(2):449-454. PubMed ID: 31773496
[TBL] [Abstract][Full Text] [Related]
27. Variations of C3 and C4 Before and During Pregnancy in Systemic Lupus Erythematosus: Association With Disease Flares and Obstetric Outcomes.
Crisafulli F; Andreoli L; Zucchi D; Reggia R; Gerardi MC; Lini D; Tani C; Zatti S; Franceschini F; Mosca M; Tincani A
J Rheumatol; 2023 Oct; 50(10):1296-1301. PubMed ID: 37127323
[TBL] [Abstract][Full Text] [Related]
28. Effects on serum complement of normal and pre-eclamptic pregnancy and of oral contraceptives.
Tedder RS; Nelson M; Eisen V
Br J Exp Pathol; 1975 Oct; 56(5):389-95. PubMed ID: 1212421
[TBL] [Abstract][Full Text] [Related]
29. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
30. Serum complement levels and perinatal outcome in pregnancies complicated by systemic lupus erythematosus.
Devoe LD; Loy GL
Obstet Gynecol; 1984 Jun; 63(6):796-800. PubMed ID: 6728360
[TBL] [Abstract][Full Text] [Related]
31. Immunological studies on pre-eclampsia in Nigerian women.
Okerengwo AA; Williams AI; Ibeziako PA
Int J Gynaecol Obstet; 1990 Oct; 33(2):121-5. PubMed ID: 1976544
[TBL] [Abstract][Full Text] [Related]
32. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
He C; Mao T; Feng Y; Song T; Qin C; Yan R; Feng P
Lupus; 2015 Nov; 24(13):1370-6. PubMed ID: 26048288
[TBL] [Abstract][Full Text] [Related]
33. Hypercatabolism of C3 and C4 in active and inactive systemic lupus erythematosus.
Charlesworth JA; Peake PW; Golding J; Mackie JD; Pussell BA; Timmermans V; Wakefield D
Ann Rheum Dis; 1989 Feb; 48(2):153-9. PubMed ID: 2784659
[TBL] [Abstract][Full Text] [Related]
34. A prospective study of serum complement (C3 and C4) levels in normal human pregnancy: effect of the development of pregnancy-associated hypertension.
Gallery ED; Raftos J; Gyory AZ; Wells JV
Aust N Z J Med; 1981 Jun; 11(3):243-5. PubMed ID: 6945834
[TBL] [Abstract][Full Text] [Related]
35. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
Whaley K; Schur PH; Ruddy S
Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Serum Ferritin Concentration in Mild and Severe Pre-Eclamptic Women.
Yesmin F; Islam MS; Ferdoushi S; Faisal FM; Rehena Z; Afroza F; Sarkar S; Rahman MQ; Ahmed AN
Mymensingh Med J; 2016 Jan; 25(1):119-25. PubMed ID: 26931260
[TBL] [Abstract][Full Text] [Related]
37. [Components of the classical complement pathway in systemic lupus erythematosus].
Maillet F; Goetz J; Hauptmann G; Clauvel JP; Mery JP; Kahn MF; Kazatchkine M
Presse Med; 1987 Mar; 16(8):378-82. PubMed ID: 2950498
[TBL] [Abstract][Full Text] [Related]
38. Anti-prolactin autoantibodies in pregnant women with systemic lupus erythematosus: maternal and fetal outcome.
Leaños-Miranda A; Cárdenas-Mondragón G; Ulloa-Aguirre A; Isordia-Salas I; Parra A; Ramírez-Peredo J
Lupus; 2007; 16(5):342-9. PubMed ID: 17576736
[TBL] [Abstract][Full Text] [Related]
39. Sub-setting systemic lupus erythematosus by combined molecular phenotypes defines divergent populations in two phase III randomized trials.
Petri M; Watts SD; Higgs RE; Linnik MD
Rheumatology (Oxford); 2021 Nov; 60(11):5390-5396. PubMed ID: 33580248
[TBL] [Abstract][Full Text] [Related]
40. Maternal disease activity and serological activity as predictors of adverse pregnancy outcomes in women with systemic lupus erythematosus: a retrospective chart review.
Murata T; Kyozuka H; Fukuda T; Toba N; Kanno A; Yasuda S; Yamaguchi A; Nomura Y; Kanno T; Migita K; Fujimori K
Arch Gynecol Obstet; 2022 May; 305(5):1177-1183. PubMed ID: 34535802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
